{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:56:06Z","timestamp":1790916966504,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to describe the temporal trends, regional distribution of dermatology services, and the hospitalization burden of common skin diseases in China (2011\u20132023) and provide reference for the government about resource allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data on dermatology outpatient visits and discharges from public hospitals by age and provinces were sourced from\n                      <jats:italic>the China Health Statistics Yearbook.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 2011 to 2023, the total number of dermatology outpatient visits and inpatient discharges from public hospitals in China were 1.36 billion and 7.38 million, respectively. Both the number and rate of outpatient and inpatient increased until 2019, declined in 2020, and rebound after 2021. Outpatient visits were highest in the eastern region, whereas inpatients were highest in the western region. The top five provinces for total outpatient visits were Guangdong, Zhejiang, Jiangsu, Shanghai, and Sichuan, for inpatient discharges from public hospitals: Hubei, Sichuan, Shandong, Guangdong, and Henan. Among four skin diseases, eczema\/dermatitis had the most hospitalizations (1,209,754), followed by urticaria (719,610), benign skin tumors (653,036), and psoriasis (370,409). Total hospitalization cost for the four diseases was 14.66 billion RMB, with eczema\/dermatitis accounting for the largest share (6.23 billion). Psoriasis had the longest hospital stay (median 11.58\u202fdays) and highest cost (median 8,880.66 RMB) per patient. Hospitalized for benign skin tumors, psoriasis, eczema\/dermatitis, and urticaria were mainly in the 15\u201344, 15\u201344, \u226560 and 5\u201344 age group, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The burden of skin diseases in China showed an increased trend before the COVID-19 pandemic. Dermatology service in China showed an east\u2013west inverse pattern between outpatient and inpatient care. Resource allocation should consider both outpatient and inpatient data. Eczema\/dermatitis had the highest hospitalization burden, while psoriasis had the longest stays and highest costs. Meanwhile, age-stratified strategies should be implemented in skin diseases clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1917511","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:41:29Z","timestamp":1790916089000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of dermatology outpatient and inpatient services in China, 2011\u20132023"],"prefix":"10.3389","volume":"14","author":[{"given":"Jingyi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Dermatology, Huizhou First Hospital","place":["Huizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University)","place":["Zhuhai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"861115","DOI":"10.3389\/fmed.2022.861115","article-title":"Global burden of bacterial skin diseases: a systematic analysis combined with sociodemographic index, 1990-2019","volume":"9","author":"Yi","year":"2022","journal-title":"Front Med (Lausanne)."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/s0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/bjd\/ljaf071","article-title":"Global burden of skin and subcutaneous diseases: an update from the global burden of disease study 2021","volume":"192","author":"Pengcheng","year":"2025","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00403-024-03046-5","article-title":"The burden of skin diseases in China: global burden of disease study 2019","volume":"316","author":"Yaoyao","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1677296","DOI":"10.3389\/fmed.2026.1677296","article-title":"Epidemiological trends and future burden of skin and subcutaneous diseases in China: insights from the global burden of disease study 2021","volume":"13","author":"Zhongsong","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/cm9.0000000000003636","article-title":"Regional and local burden of psoriasis in China, 1990-2021: findings from the global burden of disease study 2021","volume":"139","author":"Haihui","year":"2025","journal-title":"Chin Med J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ijd.70085","article-title":"Burden of atopic dermatitis in China and its provinces, 1990-2021: a global burden of disease 2021 analysis","volume":"64","author":"Weijia","year":"2025","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s00403-025-04051-y","article-title":"Urticaria in China: incidence, prevalence, and disability-adjusted life years compared with G20 countries: findings from the global burden of disease study 2021","volume":"317","author":"Weijia","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/s0140-6736(19)32136-1","article-title":"10 years of health-care reform in China: progress and gaps in universal health coverage","volume":"394","author":"Yip","year":"2019","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.2147\/ppa.s436794","article-title":"Predictors of medical care delay or avoidance among Chinese adults during the COVID-19 pandemic","volume":"17","author":"Lili","year":"2023","journal-title":"Patient Prefer Adherence"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jaad.2020.02.030","article-title":"What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?","volume":"82","author":"Yusha","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e14950","DOI":"10.1111\/dth.14950","article-title":"Dermatology outpatient clinic outcomes after COVID-19 outbreak: what is new normal?","volume":"34","author":"Ceyda","year":"2021","journal-title":"Dermatol Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.2147\/rmhp.s541047","article-title":"Impact of enhanced outpatient pooling level on healthcare utilization, costs and fund expenditures in China: an interrupted time series analysis","volume":"18","author":"Wu","year":"2025","journal-title":"Risk Manag Healthc Policy"},{"key":"ref14","year":"2022"},{"key":"ref15","first-page":"127","author":"Jian","year":"2017"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e0144809","DOI":"10.1371\/journal.pone.0144809","article-title":"Study on equity and efficiency of health resources and services based on key indicators in China","volume":"10","author":"Xinyu","year":"2015","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"04008","DOI":"10.7189\/jogh.15.04008","article-title":"Geographic variations, temporal trends, and equity in healthcare resource allocation in China, 2010-21","volume":"15","author":"Shaohua","year":"2025","journal-title":"J Glob Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12913-021-06348-w","article-title":"Equity analysis of Chinese physician allocation based on Gini coefficient and Theil index","volume":"21","author":"Huimin","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/bjd\/ljad339","article-title":"Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study","volume":"190","author":"Jingru","year":"2023","journal-title":"Br J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3390\/healthcare13192424","article-title":"The impact of DRG-based payment reform on inpatient healthcare utilization: evidence from a natural experiment in China","volume":"13","author":"Hua","year":"2025","journal-title":"Healthcare (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.7150\/ijms.67083","article-title":"The length of stay and inpatient burden in inpatients with different psoriasis subtypes","volume":"19","author":"Wang","year":"2022","journal-title":"Int J Med Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2585419","DOI":"10.1080\/09546634.2025.2585419","article-title":"Temporal trends and real-world effectiveness of biologic therapies in generalized pustular psoriasis: a 7-year retrospective cohort study","volume":"36","author":"Bin","year":"2025","journal-title":"J Dermatolog Treat"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2247106","DOI":"10.1080\/09546634.2023.2247106","article-title":"The economic burden and quality of life of patients with psoriasis treated with biologics in China","volume":"34","author":"Min","year":"2023","journal-title":"J Dermatolog Treat"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/1346-8138.17132","article-title":"Epidemiological analysis of the patients with psoriasis in Asian countries and region using the same clinical case cards between 2020 and 2022","volume":"51","author":"Michio","year":"2024","journal-title":"J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12889-025-25758-7","article-title":"Global and regional trends in psoriasis burden (1990-2021): age patterns and socio-demographic associations","volume":"26","author":"Shunsheng","year":"2025","journal-title":"BMC Public Health"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.18632\/aging.102946","article-title":"Aging-associated alterations in epidermal function and their clinical significance","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.12372\/jcp.2022.21e1750","article-title":"Retrospective analysis of 698 children with chronic spontaneous urticaria","volume":"40","author":"Xiao","year":"2022","journal-title":"J Clin Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/biomedicines11020410","article-title":"Prevalence of autoimmune and autoinflammatory diseases in chronic urticaria: pathogenetic, diagnostic and therapeutic implications","volume":"11","author":"Giuseppe","year":"2023","journal-title":"Biomedicine"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/itt.s266410","article-title":"The emerging role of IL-17 in the immune-pathogenesis of chronic spontaneous urticaria","volume":"9","author":"Elias","year":"2020","journal-title":"Immunotargets Ther"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1917511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:41:33Z","timestamp":1790916093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1917511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2026.1917511"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1917511","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1917511"}}